Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com..
An epidemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has spread unexpectedly in Wuhan, Hubei Province, China, since December 2019. There are few reports about asymptomatic contacts of infected patients identified as positive for SARS-CoV-2 through screening. We studied the epidemiological and clinical outcomes in 55 asymptomatic carriers who were laboratory confirmed to be positive for SARS-CoV-2 through nucleic acid testing of pharyngeal swab samples. The asymptomatic carriers seldom occurred among young people (aged 18-29 years) who had close contact with infected family members. In the majority of patients, the outcome was mild or ordinary 2019 novel coronavirus disease during hospitalization.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:221 |
---|---|
Enthalten in: |
The Journal of infectious diseases - 221(2020), 11 vom: 11. Mai, Seite 1770-1774 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wang, Yanrong [VerfasserIn] |
---|
Links: |
---|
Themen: |
2494G1JF75 |
---|
Anmerkungen: |
Date Completed 20.05.2020 Date Revised 10.01.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.1093/infdis/jiaa119 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM307665704 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM307665704 | ||
003 | DE-627 | ||
005 | 20231225130048.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/infdis/jiaa119 |2 doi | |
028 | 5 | 2 | |a pubmed24n1025.xml |
035 | |a (DE-627)NLM307665704 | ||
035 | |a (NLM)32179910 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wang, Yanrong |e verfasserin |4 aut | |
245 | 1 | 0 | |a Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.05.2020 | ||
500 | |a Date Revised 10.01.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com. | ||
520 | |a An epidemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has spread unexpectedly in Wuhan, Hubei Province, China, since December 2019. There are few reports about asymptomatic contacts of infected patients identified as positive for SARS-CoV-2 through screening. We studied the epidemiological and clinical outcomes in 55 asymptomatic carriers who were laboratory confirmed to be positive for SARS-CoV-2 through nucleic acid testing of pharyngeal swab samples. The asymptomatic carriers seldom occurred among young people (aged 18-29 years) who had close contact with infected family members. In the majority of patients, the outcome was mild or ordinary 2019 novel coronavirus disease during hospitalization | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a SARS coronavirus 2 | |
650 | 4 | |a asymptomatic infection | |
650 | 4 | |a outcome | |
650 | 7 | |a Antiviral Agents |2 NLM | |
650 | 7 | |a Drug Combinations |2 NLM | |
650 | 7 | |a lopinavir-ritonavir drug combination |2 NLM | |
650 | 7 | |a Lopinavir |2 NLM | |
650 | 7 | |a 2494G1JF75 |2 NLM | |
650 | 7 | |a Ritonavir |2 NLM | |
650 | 7 | |a O3J8G9O825 |2 NLM | |
700 | 1 | |a Liu, Yingxia |e verfasserin |4 aut | |
700 | 1 | |a Liu, Lei |e verfasserin |4 aut | |
700 | 1 | |a Wang, Xianfeng |e verfasserin |4 aut | |
700 | 1 | |a Luo, Nijuan |e verfasserin |4 aut | |
700 | 1 | |a Li, Ling |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of infectious diseases |d 1945 |g 221(2020), 11 vom: 11. Mai, Seite 1770-1774 |w (DE-627)NLM000005819 |x 1537-6613 |7 nnns |
773 | 1 | 8 | |g volume:221 |g year:2020 |g number:11 |g day:11 |g month:05 |g pages:1770-1774 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/infdis/jiaa119 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 221 |j 2020 |e 11 |b 11 |c 05 |h 1770-1774 |